Abstract:Although the drug-eluting stent (DES) has become the standard for percutaneous coronary intervention (PCI)-based revascularization, concerns remain regarding the use of DES, mainly due to its permanent rigid constraint to vessels. A drug-eluting bioresorbable stent (BRS) was thus developed as an alternative to DES, which can be absorbed entirely after its therapeutic period. Magnesium (Mg)-based BRSs have attracted a great deal of attention due to their suitable mechanical properties, innovative chemical features, and well-proven biocompatibility. However, the primary disadvantage of Mg-based BRSs is the rapid degradation rate, resulting in the early loss of structural support long before the recovery of vascular function. Recently, a new type of patented Mg–Nd–Zn-Zr alloy (JDBM) was developed at Shanghai Jiao Tong University to reduce the degradation rate compared to commercial Mg alloys. In the present investigation, a poly(d,l-lactic acid)-coated and rapamycin eluting (PDLLA/RAPA) JDBM BRS was prepared, and its biosafety and efficacy for coronary artery stenosis were evaluated via in vitro and in vivo experiments. The degree of smooth muscle cell adhesion to the PDLLA/RAPA coated alloy and the rapamycin pharmacokinetics of JDBM BRS were first assessed in vitro. JDBM BRS and commercial DES FIREHAWK were then implanted in the coronary arteries of a porcine model. Neointimal hyperplasia was evaluated at 30, 90, and 180 days, and re-endothelialization was evaluated at 30 days. Furthermore, Micro-CT and optical coherence tomography (OCT) analyses were performed 180 days after stent implantation to evaluate the technical feasibility, biocompatibility, and degradation characteristics of JDBM BRS in vivo. The results show the ability of a PDLLA/RAPA coated JDBM to inhibit smooth muscle cell adhesion and moderate the drug release rate of JDBM BRS in vitro. In vivo, low local and systemic risks of JDBM BRS were demonstrated in the porcine model, with preserved mechanical integrity after 6 months of implantation. We also showed that this novel BRS was associated with a similar efficacy profile compared with standard DES and high anti-restenosis performance. These findings may confer long term advantages for using this BRS over a traditional DES.

Study on Inhibition of Lumen Reduction in Peripheral Artery and Neointimal Hyperplasia with a Novel Dexamethasone-Heparin-double Coated Stent Using Zein As Carrier in Porcine.

In Vivo Evaluation of A Novel Dexamethasone-Heparin-Double-Coated Stent for Inhibition of Artery Restenosis and Thrombosis

Preventive effect of a novel dexamethasone-heparin coated stent on restenosis in a porcine artery injury model

A novel biodegradable polymer coated,sirolimus-eluting stent: evaluation in a porcine coronary model

Polymer-free Dual Drug-Eluting Stents Evaluated in a Porcine Model

A novel biodegradable polymer-coated cobalt-chromium alloy sirolimus-eluting stent：evaluation in a porcine model

Evaluation of a novel polymer-free sirolimus-eluting stent in a porcine model

Assessment of an Asymmetrical Coating Stent with Sirolimus Released from Ablumial Matrix in Porcine Model

Effect of Rapamycin Eluting Stent for Inhibition of Neointimal Hyperplasia in Diabetic Porcine Model

A Biodegradable-Polymer-plga-coated,sirolimus-eluting Cobalt-chromium Alloy Stent:Safety and Efficacy Evaluation in a Porcine Model

Experimental Study of 103pd Stents for Preventing the Restenosis of Biliary Duct

Paclitaxel-eluting Stent Inhibits Restenosis in Peripheral Artery in a Swine Model of Diabetes: an Experiment Study

A cell membrane like biomimetic drug-eluting coronary stent

Safety and Efficacy of Cobalt Chromium Alloy Based Sirolimus-Eluting Stent with Bioabsorbable Polymer in Porcine Model.

Evaluation of a Novel Paclitaxel-Eluting Stent with a Bioabsorbable Polymeric Surface Coating in the Porcine Artery Injury Model

Biosafety and Efficacy Evaluation of a Biodegradable Zn-Cu-Mn Stent: A Long-Term Study in Porcine Coronary Artery

A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries.

High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo

Long-Term Effects of Novel Biodegradable, Polymer-Coated, Sirolimus-Eluting Stents on Neointimal Formation in A Porcine Coronary Model

Biosafety and Efficacy Evaluation of a Biodegradable Magnesium Based Drug-eluting Stent in Porcine Coronary Artery

Efficacy and Safety of a Novel Nano-Porous Polymer-Free Sirolimus-Eluting Stent in Pigs.